Pharmaceutical Resource Technology, Inc.

S-1/A amended

Pharmaceutical Resource Technology, Inc. is offering 100,000,000 shares of common stock at $0.50 per share through a self-underwritten, best-efforts offering. The company operates in Singapore, manufacturing dietary supplements, skincare products, and honey straws, while also engaging in building and construction services. The offering lacks a minimum share requirement, no escrow account for funds, and terminates after 365 days or upon selling all shares. The company intends to apply for OTCQB listing, though no assurance of a public market exists. The filing emphasizes speculative risks, including potential loss of investment and penny stock regulations.

S-1 filed

Pharmaceutical Resource Technology, Inc. has filed an S-1 registration statement for an upcoming IPO, marking a new attempt after previously withdrawing an S-1 in 2021. The company, based in Singapore and incorporated in Wyoming, aims to raise capital through a securities offering. The filing emphasizes that the offering price is arbitrary, with no assurance of market value or liquidity for shares. The company qualifies as an emerging growth and smaller reporting company, indicating limited operating history and potential regulatory flexibility.

RW withdrawn

Jaison Phyotchem, Inc. submitted a withdrawal request for its previously filed Registration Statement on Form S-1, effective immediately. The company cited the need for additional time and resources to pursue a future S-1 filing. The withdrawn registration had not been declared effective, and no securities were sold under it. Fees paid to the SEC are being requested for future use.

S-1 filed

Jaison Phytochem, Inc. is a newly incorporated company seeking to raise capital through an S-1 filing, offering 56,623,000 shares of common stock at $0.50 per share. The company plans to use proceeds for operations, including manufacturing honey straws via licensing agreements with Superbee Network Singapore Pte Ltd. No public market exists for its shares, and it aims to list on OTC Pink after securing a market maker. The offering is self-underwritten with no minimum purchase requirements, and the company has no revenue or operating history.